1997
DOI: 10.1007/s000110050163
|View full text |Cite
|
Sign up to set email alerts
|

Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models

Abstract: Tenidap inhibits 5-lipoxygenase activity in vitro both directly and indirectly by interfering with its translocation from cytosol to the membrane compartment in neutrophils. A potential mechanism for the latter effect is discussed with reference to tenidap's ability to lower intracellular pH. Tenidap did not inhibit 5-LO pathway activity in three animal models.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Although some drugs may have shown the capacity to inhibit both 5-LO and COX in vitro, this did not always translate in vivo (42). LTB 4 , a product of the 5-LO pathway, is known to be an important mediator of a number of inflammatory responses.…”
Section: Discussionmentioning
confidence: 99%
“…Although some drugs may have shown the capacity to inhibit both 5-LO and COX in vitro, this did not always translate in vivo (42). LTB 4 , a product of the 5-LO pathway, is known to be an important mediator of a number of inflammatory responses.…”
Section: Discussionmentioning
confidence: 99%
“…In order to measure peritoneal leukotriene B 4 levels a modification of a previously described procedure was followed 17 . Animals received a 5‐mL intraperitoneal injection of saline containing 50 μg/mL heparin; 10 min later a laparotomy was performed and the peritoneal fluid was collected and centrifuged.…”
Section: Methodsmentioning
confidence: 99%